Monkeypox vaccine maker raises concerns about plan to split doses
The CEO of the company that makes the only Food and Drug Administration (FDA)-approved vaccine to prevent monkeypox told Biden administration health officials he was concerned about a new strategy to split doses and change the way the vaccine is injected. In a letter shared with The Hill, Bavarian Nordic CEO Paul Chaplin said the …
Monkeypox vaccine maker raises concerns about plan to split doses Read More »
